Evidence map›Paper›PMID 35047572›Full record

ArticleFrontiers in cardiovascular medicine2021

Favorable Cardiovascular Health Is Associated With Lower Hepatocyte Growth Factor Levels in the Multi-Ethnic Study of Atherosclerosis.

Olatokunbo Osibogun, Oluseye Ogunmoroti, Richard A Ferraro, Chiadi E Ndumele, Gregory L Burke, Nicholas B Larson, Suzette J Bielinski, Erin D Michos

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olatokunbo OsibogunDepartment of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida international University, Miami, FL, United States.
Oluseye OgunmorotiCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Richard A FerraroCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Chiadi E NdumeleCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Gregory L BurkeDivision of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Nicholas B LarsonDivision of Clinical Trials and Biostatistics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Suzette J BielinskiDivision of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Erin D MichosCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Funding

Multi-Scale Biology of Atherosclerosis in the Cellular Adhesion PathwayR01HL098077 · NHLBI · MAYO CLINIC ROCHESTER · PI BIELINSKI, SUZETTE JANINE · 2010 to 2014
$2.8M
NHLBI NIH HHS R01 HL098077
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercardiovascular diseasehepatocyte growth factorideal cardiovascular health metricslife's simple 7risk factors

Identifiers

PMID35047572
PMCPMC8761906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.